Connect with us on Facebook Follow us on Twitter Join our LinkedIn Group Subscribe to us on YouTube Share with us on Google+ Subscribe to our RSS feed

January 01, 2010

Financial News

Financial News, January 2010

Third Quarter Results


Tiens Biotech Group (USA)

Tiens Biotech Group (USA) Inc. (TBV—NYSE) announced that revenue for the third quarter of 2009 was $9.4 million, compared to $26.2 million for the third quarter of 2008. Net income for the third quarter of 2009 was $2.9 million, or 3 cents per share, compared to net income of $14.6 million, or 20 cents per share, for the third quarter of 2008.

Revenue for the nine months ended Sept. 30, 2009, was $48.2 million, compared to $58.7 million for the nine months ended Sept. 30, 2008, reflecting the aforementioned decrease in sales in China. Net income for the nine months ended Sept. 30, 2009, was $22.2 million, or 29 cents per share, compared to $24.8 million, or 32 cents per share, for the nine months ended Sept. 30, 2008.

Tiens Biotech Group (USA) Inc. conducts its business operations from Tianjin, People’s Republic of China. Tiens primarily engages in the research, development, manufacturing and marketing of nutrition-supplement products, including wellness products and dietary supplements. Tiens derives its revenue principally from product sales to affiliated companies in China and in 52 countries.

GeneLink Inc.

GeneLink Inc. (GNLK.OB—OTC BB) reported that for the past three months, net sales were $2,134,504, compared to $2,113,177 in the previous quarter, and quarterly gross profit was $1,265,176, compared to $1,175,645 in the previous quarter.

Total revenues for the three months ended Sept. 30, 2009, were $2,134,504, compared to $2,113,177 for the three months ended June 30, 2009, an increase of 1 percent. Quarterly gross profit increased by 7.6 percent to $1,265,176 for the three months ended Sept. 30, 2009, compared to $1,175,645 for the three months ended June 30, 2009, as gross profit margin improved to 59.3 percent from 55.6 percent.

GeneWize, a direct sales company, focuses exclusively on providing individually customized nutritional and skincare formulations based on a consumer’s personal genetic assessment. The company empowers individuals to take personal responsibility and control of their health.

RBC Life Sciences Inc.

RBC Life Sciences Inc. (RBCL—OTC Bulletin Board) reported companywide net sales of $6.49 million for the quarter ended Sept. 30, 2009, compared to net sales of $9.93 million for the same quarter last year.

The company also reported a net loss of $152,000, or 1 cent per share, during the third quarter of 2009, compared to net earnings of $846,000, or 4 cents per share, during the same quarter in 2008.

RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal-care products to a growing population of consumers seeking wellness and a healthy lifestyle.

Natural Health Trends Corp.

Natural Health Trends Corp. (BHIP—Pink Sheets) announced its financial results for the quarter ended Sept. 30, 2009. The company reported sales of $5.7 million and an operating loss of $1.7 million for the quarter.

Natural Health Trends Corp. is an international direct selling and e-commerce company operating through its subsidiaries throughout Asia, North America and Europe.

The company markets premium-quality personal-care products under the NHT Global brand.

The Amacore Group

The Amacore Group Inc. (ACGI—OTC BB) reports that during the third quarter total revenue was $7.1 million, compared to $8.6 million in the year-ago quarter. Included in the year-ago quarter revenue was revenue generated from a marketer with whom Amacore has discontinued its relationship because of the high cost of sales and lower-than-anticipated billing and retention performance.

The Amacore Group Inc. is primarily a provider and marketer of healthcare-related products, including healthcare benefits, vision and dental networks, and administrative services such as billing, fulfillment, patient advocacy, claims administration and servicing. Zurvita, its multilevel marketing subsidiary, is a provider of products and benefits in healthcare and other niche markets.

YTB International

YTB International Inc. (YTBLA—OTC BB) announced its total revenue for the quarter ended Sept. 30, 2009, decreased 62 percent to $15.9 million, compared to $42.2 million for the third quarter of 2008. Net income for the quarter ended Sept. 30, 2009, improved to $0.36 million, or no cents per diluted share, compared to a net income of $0.29 million, or no cents per diluted share, for the same period of 2008. The decline in revenue during the  third quarter of 2009 was primarily attributable to a decline in the number of new Internet Business Centers (IBCs) sold during the quarter and a decrease in the number of active IBC site owners.

YTB International Inc. provides Internet-based travel-booking services for home-based independent representatives in the United States, Puerto Rico, the Bahamas, Canada, Bermuda and the U.S. Virgin Islands. The company operates through three subsidiaries: Inc., YTB Travel Network Inc. and REZconnect Technologies Inc.